This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Facts about Leucine-rich repeat serine/threonine-protein kinase 2.
Together with RAB29, plays a role in the retrograde trafficking pathway for recycling proteins, such as mannose 6 phosphate receptor (M6PR), between lysosomes and the Golgi apparatus in a retromer-dependent method. Regulates neuronal process morphology in the whole central nervous system (CNS).
Mouse | |
---|---|
Gene Name: | Lrrk2 |
Uniprot: | Q5S006 |
Entrez: | 66725 |
Belongs to: |
---|
protein kinase superfamily |
augmented in rheumatoid arthritis 17; AURA17; Dardarin; DKFZp434H2111; EC 2.7.11.1; FLJ45829; leucine-rich repeat kinase 2; leucine-rich repeat serine/threonine-protein kinase 2; LRRK2; PARK8; PARK8DARDARIN; Parkinson disease (autosomal dominant) 8; RIPK7; ROCO2
Mass (kDA):
284.732 kDA
Mouse | |
---|---|
Location: | 15|15 E3 |
Sequence: | 15; |
Expressed in the brain (at protein level). Detected throughout the adult brain. Expressed in deep cerebral cortex layers, superficial cingulate cortex layers, the piriform cortex, hippocampal formation, caudate putamen, substantia nigra, the basolateral and basomedial anterior amygdala nuclei, reticular thalamic nucleus and also in the cerebellar granular cell layer. Highly expressed in the striatum, cortex and olfactory tubercle. Little or no expression in the substantia nigra, where dopaminergic neurons preferentially degenerate in Parkinson disease. Expression is particularly high in brain dopaminoceptive areas. High and strikingly specific expression in striatum and parts of cortex and no signals in dopamine neurons.
PMID: 15541309 by Zimprich A., et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology.
PMID: 16532471 by Galter D., et al. LRRK2 expression linked to dopamine-innervated areas.